Fig. 9From: A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancerBiodistribution comparison of doxorubicin from GNP theranostic nanomedicine in liver, kidney, heart and tumour after IV and PO dose, at different time points. a Graph confirmed the reduction of doxorubicin in liver tissue with the passage of time. b Doxorubicin eliminated from the heart quickly. c Doxorubicin concentration was decreased with time and showed quick elimination from the body. d Oral administration showed most of the drug was bound to the target site, while after IV administration only a little amount was able to reach at the targeted site but that little amount was able to show effect until 48Â hBack to article page